LYNKUET caps moll 60 mg 60 pce

7680699170029 Pharmacode 1146277 CH-69917 G02CX07 09.98.0.
LYNKUET caps moll 60 mg 60 pce
LYNKUET caps moll 60 mg 60 pce
LYNKUET caps moll 60 mg 60 pce
1 / 3
google

Details

GTIN
7680699170029
Pharmacode
1146277
Product number
6991701
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
elinzanetantum 60 mg, int-rac-alpha-tocopherolum, macrogolglyceridorum caprylocaprates, glyceroli monocaprylocapras, glyceroli mono-oleas, polysorbatum 80, Kapselhülle: E 172 (rubrum), E 172 (flavum), gelatina, sorbitolum liquidum partim deshydricum corresp. sorbitolum 75 mg, glycerolum, E 171, Drucktinte: ammoniae solutio concentrata, alcohol isopropylicus, macrogolum 400, propylenglycolum, polyvinylis acetas phtalas, aqua purificata, ethanolum, ethylis acetas, E 171, pro capsula.

Articles (1)

Lynkuet 60 mg, Weichkapseln
Weichkapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/08/2026
Patient information leaflet
Français
04/08/2026
Patient information leaflet
Italien
04/08/2026
Professional SmPC
Allemand
04/08/2026
Professional SmPC
Français
04/08/2026
Professional SmPC
Italien
04/08/2026

Detailed composition

Substance Quantity Type Category
elinzanetantum
60.0 MG Substance Wirkstoff (Principe actif)
int-rac-alpha-tocopherolum
- Substance HNIDK
macrogolglyceridorum caprylocaprates
- Substance HNIDK
glyceroli monocaprylocapras
- Substance HNIDK
glyceroli mono-oleas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
gelatina
- Substance HNIDK
sorbitolum liquidum partim deshydricum
- Substance HNIDK
sorbitolum
75.0 MG Substance HBESI
glycerolum
- Substance HNIDK
E 171
- Substance FNIDK
ammoniae solutio concentrata
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polyvinylis acetas phtalas
- Substance HNIDK
aqua purificata
- Substance HNIDK
ethanolum
- Substance HNIDK
ethylis acetas
- Substance HNIDK
E 171
- Substance FNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
69917
Drug name
Lynkuet, Weichkapseln
Galenic form
KAPWE
ATC Code
G02CX07
Authorization status
Z
Dispensation category
B
First authorization
05/08/2025
Authorization expiration date
04/08/2030
IT number
09.98.0.
Domain
Human medicine
Field of application
Behandlung moderater bis schwerer vasomotorischer Symptome (VMS) -bei postmenopausalen Patientinnen -die durch adjuvante endokrine Therapie im Zusammenhang mit Brustkrebs bei erwachsenen Patientinnen verursacht werden

Packaging details

Description (FR)
LYNKUET caps moll 60 mg 60 pce
Description (DE)
LYNKUET Weichkaps 60 mg 60 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other packaging sizes

LYNKUET caps moll 60 mg 24 pce
24 KAP
View
Buy us a coffee Explore the data